Did you know. . . 

  • Barnabas Heart is one of a small number of centers in the US that are able to offer TAVR to patients considered low risk for surgical AVR as part of the FDA approved PARTNER 3 Trial
  • Barnabas performed the 2nd low risk in the US
  • Outside of clinical trials, TAVR is currently only available to patients considered high and moderate-risk for open heart surgery. However, TAVR has been so effective in treating higher risk patients, it is now being studied as an alternative for lower risk patients.
  • The Lancet recently reported that in patients considered intermediate risk for surgical aortic valve replacement, the risk of death and stroke was reduced by nearly 50 percent among patients undergoing TAVR compared to traditional open heart surgery.​
​For more information about Low Risk TAVR and PARTNER 3 Trial call 973-926-8032.

What is aortic stenosis?

What are the symptoms of aortic stenosis?

What information is needed before I can undergo the procedure?

What is transcatheter aortic valve replacement (TAVR)?

Related Topics

Learn about TAVR at Barnabas Heart